Shattuck is a clinical-stage life science company treating cancer and other autoimmune diseases. Its two locations, in Durham and Austin, employ 50 people, two-thirds of whom call the Triangle their home.
Read More
Shattuck Labs, a life science startup focusing on development of new treatments for cancer and autoimmune disease, is going public today and expects to raise $202 million the process.
Read More
Just a mile down the road from the North Carolina Biotechnology Center, Shattuck Labs is changing the face of cancer therapy. Here’s a look at the company, its technology and its CEO.
Read More
Shattuck Labs, a life science startup focusing on development of new treatments for cancer and autoimmune disease, has closed on $118 million in new financing and also secured Durham-based Hatteras Venture Partners as a backer.
Read More
